A detailed history of Engineers Gate Manager LP transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 19,389 shares of PCRX stock, worth $419,965. This represents 0.02% of its overall portfolio holdings.

Number of Shares
19,389
Holding current value
$419,965
% of portfolio
0.02%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$27.7 - $35.48 $537,075 - $687,921
19,389 New
19,389 $566,000
Q3 2023

Nov 14, 2023

BUY
$30.68 - $40.09 $285,139 - $372,596
9,294 New
9,294 $285,000
Q1 2023

May 15, 2023

SELL
$35.53 - $43.38 $1.26 Million - $1.54 Million
-35,406 Reduced 67.96%
16,693 $681,000
Q4 2022

Feb 14, 2023

BUY
$38.19 - $57.45 $1.99 Million - $2.99 Million
52,099 New
52,099 $2.01 Million
Q3 2021

Nov 15, 2021

SELL
$54.64 - $61.3 $929,426 - $1.04 Million
-17,010 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$59.18 - $69.99 $44,385 - $52,492
750 Added 4.61%
17,010 $1.03 Million
Q1 2021

May 17, 2021

BUY
$59.31 - $78.82 $700,984 - $931,573
11,819 Added 266.13%
16,260 $1.14 Million
Q4 2020

Feb 16, 2021

BUY
$50.47 - $66.26 $9,084 - $11,926
180 Added 4.22%
4,441 $266,000
Q3 2020

Nov 16, 2020

BUY
$51.97 - $63.0 $221,444 - $268,443
4,261 New
4,261 $256,000
Q2 2020

Aug 17, 2020

SELL
$30.8 - $52.47 $1.39 Million - $2.38 Million
-45,266 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$28.4 - $50.7 $616,251 - $1.1 Million
-21,699 Reduced 32.4%
45,266 $1.52 Million
Q4 2019

Feb 14, 2020

BUY
$36.31 - $46.83 $2.43 Million - $3.14 Million
66,965 New
66,965 $3.03 Million
Q3 2019

Nov 14, 2019

SELL
$35.66 - $44.99 $2.74 Million - $3.46 Million
-76,881 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$36.57 - $47.97 $374,769 - $491,596
-10,248 Reduced 11.76%
76,881 $3.34 Million
Q1 2019

May 15, 2019

BUY
$36.47 - $42.17 $901,210 - $1.04 Million
24,711 Added 39.59%
87,129 $3.32 Million
Q4 2018

Feb 14, 2019

SELL
$41.31 - $52.16 $385,628 - $486,913
-9,335 Reduced 13.01%
62,418 $2.69 Million
Q3 2018

Nov 01, 2018

BUY
$32.85 - $52.0 $352,611 - $558,168
10,734 Added 17.59%
71,753 $3.53 Million
Q2 2018

Aug 03, 2018

BUY
$27.5 - $39.8 $1.68 Million - $2.43 Million
61,019 New
61,019 $1.96 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $993M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.